Technology Insight: imaging neurodegeneration in Parkinson's disease

被引：0
|
作者：
David J Brooks
机构：
[1] DJ Brooks is Hartnett Professor of Neurology in the Faculty of Medicine at Imperial College,
[2] and Head of the Neurology Group at the Medical Research Council Clinical Sciences Centre at Hammersmith Hospital,undefined
[3] London,undefined
[4] and Head of Neurology,undefined
[5] Medical Diagnostics,undefined
[6] GE Healthcare,undefined
[7] Amersham,undefined
[8] UK.,undefined
来源：
Nature Clinical Practice Neurology | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Currently, idiopathic Parkinson's disease can only be diagnosed definitively by the demonstration of intracellular Lewy body inclusions on histological specimens of brain tissue—an approach that is impractical in living individuals. In this Review, David Brooks discusses recent advances in noninvasive imaging approaches that are providing important insights into the structural, pathophysiological and pharmacological changes associated with Parkinson's disease, and could have major implications for the future diagnosis and management of this condition.
引用
收藏
页码：267 / 277
页数：10
相关论文
共 50 条
  • [1] Technology Insight: imaging neuro degeneration in Parkinson's disease
    Brooks, David J.
    NATURE CLINICAL PRACTICE NEUROLOGY, 2008, 4 (05): : 267 - 277
  • [2] Imaging neurodegeneration in Parkinson's disease
    Pavese, Nicola
    Brooks, David J.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07): : 722 - 729
  • [3] Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease
    Joers, Valerie
    Emborg, Marina E.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 4 (02): : 125 - 159
  • [4] Combating Dopaminergic Neurodegeneration in Parkinson's Disease through Nanovesicle Technology
    Roy, Rubina
    Paul, Rajib
    Bhattacharya, Pallab
    Borah, Anupom
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (16): : 2830 - 2848
  • [5] Corneal confocal microscopy: An imaging biomarker of neurodegeneration in Parkinson's disease
    Lim, S.
    Silverdale, M.
    Petropoulos, I.
    Kalteniece, A.
    Malik, R.
    Kobylecki, C.
    Ferdousi, M.
    MOVEMENT DISORDERS, 2019, 34
  • [6] Metals associated neurodegeneration in Parkinson's disease: Insight to physiological, pathological mechanisms and management
    Raj, Khadga
    Kaur, Pawandeep
    Gupta, G. D.
    Singh, Shamsher
    NEUROSCIENCE LETTERS, 2021, 753
  • [7] Ageing, neurodegeneration and Parkinson's disease
    Hindle, John V.
    AGE AND AGEING, 2010, 39 (02) : 156 - 161
  • [8] Markers of Neurodegeneration in Parkinson’s Disease
    M. A. Nikitina
    V. M. Alifirova
    S. O. Borodina
    E. S. Koroleva
    Neurochemical Journal, 2023, 17 : 338 - 348
  • [9] Glaucoma, Parkinson's disease and neurodegeneration
    Balci, Sevcan Yildiz
    Eraslan, Muhsin
    Temel, Ahmet
    MARMARA MEDICAL JOURNAL, 2015, 28 (01): : 8 - 12
  • [10] Inflammation and neurodegeneration in Parkinson's disease
    McGeer, PL
    McGeer, EG
    PARKINSONISM & RELATED DISORDERS, 2004, 10 : S3 - S7
12345